Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: Usefulness of glycated albumin as a predictor of mortality in chronic hemodialysis patients with diabetes: a multi-center, prospective cohort study

1 (1)The association of glycated albumin (GA) with mortality is unclear in chronic hemodialysis patients with diabetes. We investigated the usefulness of GA by comparing it with hemoglobin A1c (HbA1c) in this patient population.

See this article.

Featured article: Comparison of clinical effects between icodextrin and glucose solutions on outcomes of peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials

2 (1)Icodextrin enhances peritoneal filtration for patients on peritoneal dialysis (PD). However, clinically important outcomes have not yet been analyzed using authentic, objective statistical methods. The present systematic review aimed to determine the risks and benefits of icodextrin compared with a glucose-based solution with respect to clinically important and patient-centered outcomes.

See this article.

Featured article: Proposal of peritoneal biopsy procedures for patients undergoing peritoneal dialysis

3 (1)Prolonged peritoneal dialysis (PD) is responsible for progressive morphological changes such as deterioration of the peritoneal membrane. These changes increase the risk of encapsulating peritoneal sclerosis (EPS). Histological assessments of peritoneal membrane biopsy samples are fundamental for the evaluation of the peritoneal damage caused by PD.

See this article.


Upcoming conferences

The 65th Annual Meeting of the Japanese Society for Dialysis Therapy
2-3 November 2020, Osaka International Convention Center, RIHGA Royal Hotel Osaka with WEB meeting 

The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
4-6 June 2021, Pacifico Yokohama

The 67th Annual Meeting of the Japanese Society for Dialysis Therapy
30 June - 2 July 202, Pacifico Yokohama

The 26th Annual Meeting of the Japanese Society for Peritoneal Dialysis
19-20 September 2020, Keio Plaza Hotel Tokyo

The 31st Annual Meeting of the Japan Society for Blood Purification Critical Care
17-18 October 2020, Kofu Memorial Day's Hotel

The 32nd Annual Meeting of the Japan Society for Blood Purification Critical Care
2-3 October 2021, Rafre Saitama

The 33rd Annual Meeting of the Japan Society for Blood Purification Critical Care
7-8 October 2022, Juroku Plaza

The 11th Annual Meeting of the Japanese Society of Renal Rehabilitation

20-21 March 2021, Sendai International Center

The 14th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
28-29 November 2020, Awagin Hall Tokushima

The 42nd Japanese Society for Pediatrics Renal Failure
3-4 December, 2020, Osaka City Central Public Hall

Submit your manuscript

RRT logo

Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.

Aims and scope

Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.

RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.

Overcoming Language Barriers

english editingIf your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.

Society affiliations

Renal Replacement Therapy is the official publication of the following societies:

About the Editor

Prof Takashi Shigematsu, Editor-in-Chief

Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.

His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.

Annual Journal Metrics

  • Speed
    37.6 days to first decision for reviewed manuscripts only
    28.5 days to first decision for all manuscripts
    118.9 days from submission to acceptance
    25 days from acceptance to publication

    33 Altmetric mentions